Tetrahydrocannabinol and Cannabidiol for Pain Treatment—An Update on the Evidence
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(2), P. 307 - 307
Published: Jan. 29, 2024
In
light
of
the
current
International
Association
for
Study
Pain
(IASP)
clinical
practice
guidelines
(CPGs)
and
European
Society
Medical
Oncology
(ESMO)
guidelines,
topic
cannabinoids
in
relation
to
pain
remains
controversial,
with
insufficient
research
presently
available.
Cannabinoids
are
an
attractive
management
option
due
their
synergistic
effects
when
administered
opioids,
thereby
also
limiting
extent
respiratory
depression.
On
own,
however,
have
been
shown
potential
relieve
specific
subtypes
chronic
adults,
although
controversies
remain.
Among
these
neuropathic,
musculoskeletal,
cancer,
geriatric
pain.
Another
interesting
feature
is
effectiveness
chemotherapy-induced
peripheral
neuropathy
(CIPN).
Analgesic
benefits
hypothesized
extend
HIV-associated
neuropathic
pain,
as
well
lower
back
elderly.
The
aim
this
article
provide
up-to-date
review
existing
preclinical
studies,
along
relevant
systematic
reviews
addressing
roles
various
types
settings.
impact
cancer
non-cancer
conditions,
such
multiple
sclerosis
headaches,
all
discussed,
novel
techniques
administration
mechanisms
action.
Language: Английский
Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: July 13, 2024
Abstract
Cannabigerol
(CBG)
is
a
phytocannabinoid
increasing
in
popularity,
with
preclinical
research
indicating
it
has
anxiolytic
and
antidepressant
effects.
However,
there
are
no
published
clinical
trials
to
corroborate
these
findings
humans.
The
primary
objective
of
this
study
was
examine
acute
effects
CBG
on
anxiety,
stress,
mood.
Secondary
objectives
were
whether
produces
subjective
drug
or
motor
cognitive
impairments.
A
double-blind,
placebo-controlled
cross-over
field
trial
conducted
34
healthy
adult
participants.
Participants
completed
two
sessions
(with
one-week
washout
period)
via
Zoom.
In
each,
they
provided
ratings
mood,
prior
double-blind
administration
20
mg
hemp-derived
placebo
tincture
(T0).
These
collected
again
after
participants
ingested
the
product
an
online
survey
(T1),
Trier
Social
Stress
Test
(T2),
verbal
memory
test
DRUID
impairment
app
(T3).
Relative
placebo,
significant
main
effect
overall
reductions
anxiety
as
well
stress
at
T1.
also
enhanced
relative
placebo.
There
evidence
impairment.
may
represent
novel
option
reduce
adults.
Language: Английский
Effects of magnesium supplementation on muscle soreness in different type of physical activities: a systematic review
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: July 5, 2024
Magnesium
is
a
micronutrient
and
an
intracellular
cation
responsible
for
different
biochemical
reactions
involved
in
energy
production
storage,
control
of
neuronal
vasomotor
activity,
cardiac
excitability,
muscle
contraction.
deficiency
may
result
impaired
physical
performance.
Moreover,
magnesium
plays
important
role
on
delayed
onset
soreness
after
training.
Thus,
physically
active
individuals
sport
specialists
have
to
pay
attention
supplementation
(MgS).
However,
the
type,
timing
dosage
intake
are
not
well
elucidated
yet.
Hence,
we
aimed
systematically
review
literature
regarding
effects
MgS
individuals.
We
focused
exclusively
MgS,
excluding
those
studies
which
was
administered
together
with
other
substances.
Language: Английский
Opioid and Cannabinoid Systems in Pain: Emerging Molecular Mechanisms and Use in Clinical Practice, Health, and Fitness
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(17), P. 9407 - 9407
Published: Aug. 29, 2024
Pain
is
an
unpleasant
sensory
and
emotional
experience.
Adequate
pain
control
often
challenging,
particularly
in
patients
with
chronic
pain.
Despite
advances
management,
drug
addiction,
overtreatment,
or
substance
use
disorders
are
not
rare.
Hence
the
need
for
further
studies
field.
The
substantial
progress
made
over
last
decade
has
revealed
genes,
signalling
pathways,
molecules,
neuronal
networks
thus
opening
new
clinical
perspectives
management.
In
this
respect,
data
on
epigenetic
modulation
of
opioid
cannabinoid
receptors,
key
actors
pain,
offered
to
preserve
activity
endocannabinoid
systems
increase
analgesic
efficacy
opioid-
cannabinoid-based
drugs.
Similarly,
upcoming
cannabidiol
(CBD),
a
non-psychoactive
marijuana
plant
Cannabis
sativa,
suggests
analgesic,
anti-inflammatory,
antioxidant,
anticonvulsivant
ansiolitic
effects
supports
its
potential
application
contexts
such
as
cancer,
neurodegeneration,
autoimmune
diseases
but
also
health
fitness
athletes.
Hence,
review
article,
we
summarize
emerging
modifications
receptors
focus
CBD
management
practice,
health,
fitness.
Language: Английский
An Unexpected Activity of a Minor Cannabinoid: Cannabicyclol (CBL) Is a Potent Positive Allosteric Modulator of Serotonin 5-HT1A Receptor
Mehdi Haghdoost,
No information about this author
Yvonne DePorre,
No information about this author
Max Figi
No information about this author
et al.
Journal of Natural Products,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 15, 2025
Cannabicyclol
((±)-CBL),
a
minor
phytocannabinoid,
is
largely
unexplored,
with
its
biological
activity
previously
undocumented.
We
studied
conversion
from
cannabichromene
(CBC)
using
various
acidic
catalysts.
Montmorillonite
(K30)
in
chloroform
at
room
temperature
had
the
highest
yield
(60%)
minimal
byproducts.
Key
reaction
conditions,
such
as
solvent,
temperature,
and
time,
significantly
impacted
yield.
The
structure
of
(±)-CBL
was
confirmed
via
X-ray
crystallography.
Stability
studies
showed
that
MCT
oil
dilution
remain
stable
25–40
°C
for
three
months.
Radioligand
binding
assays
revealed
high
affinity
CBL
5-HT1A
receptor
but
weak
interaction
CB1
CB2
receptors.
At
10
μM
1
μM,
inhibited
[3H]-8-hydroxy-DPAT
to
by
75%
20%,
respectively.
Functional
acts
agonist
concentrations
potent
positive
allosteric
modulator
serotonin-induced
activation
low
concentrations.
4
increased
β-arrestin
recruitment
20%
80%.
This
unique
modulatory
profile
highlights
potential
drug
discovery
targeting
serotonin
Language: Английский
Cannabinoid Therapy in Athletics: A Review of Current Cannabis Research to Evaluate Potential Real-World Cannabinoid Applications in Sport
Sports Medicine,
Journal Year:
2024,
Volume and Issue:
54(11), P. 2743 - 2769
Published: Aug. 21, 2024
Language: Английский
Exploring the Potential of Nonpsychoactive Cannabinoids in the Development of Materials for Biomedical and Sports Applications
Dulexy Solano-Orrala,
No information about this author
Dennis A. Silva-Cullishpuma,
No information about this author
Eliana Díaz-Cruces
No information about this author
et al.
ACS Applied Bio Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 20, 2024
This
Perspective
explores
the
potential
of
nonpsychoactive
cannabinoids
(NPCs)
such
as
CBD,
CBG,
CBC,
and
CBN
in
developing
innovative
biomaterials
for
biomedical
sports
applications.
It
examines
their
physicochemical
properties,
anti-inflammatory,
analgesic,
neuroprotective
effects,
integration
into
various
hydrogels,
sponges,
films,
scaffolds.
also
discusses
current
challenges
standardizing
formulations,
understanding
long-term
intrinsical
regulatory
landscapes.
Further,
it
promising
applications
NPC-loaded
materials
bone
regeneration,
wound
management,
drug
delivery
systems,
emphasizing
improved
biocompatibility,
mechanical
therapeutic
efficacy
demonstrated
Language: Английский
Nutrological modulation of cannabidiol in the inflammatory processes of athletes: a systematic review
Ricardo de Oliveira Carvalho,
No information about this author
Hugo Menezes Lopes,
No information about this author
Mateus Antunes Nogueira
No information about this author
et al.
International Journal of Nutrology,
Journal Year:
2024,
Volume and Issue:
17(S3)
Published: June 13, 2024
Introduction:
The
correct
interaction
between
the
elements
of
endocannabinoid
system
plays
an
important
role
in
development
central
nervous
system.
Clinical
and
preclinical
studies
suggest
that
cannabidiol
(CBD)
may
be
useful
for
athletes
due
to
its
anti-inflammatory,
analgesic,
anxiolytic,
neuroprotective
properties
influence
on
sleep-wake
cycle.
Furthermore,
a
series
implications
epigenetic
processes
were
also
proven,
through
changes
expression
exosomes
microRNAs
responsible
modulating
immune
inflammatory
systems.
Objective:
It
was
list
main
clinical
considerations
nutritional
modulation
immunological
systematic
review.
Methods:
PRISMA
Platform
review
rules
followed.
research
carried
out
from
January
March
2024
Scopus,
PubMed,
Science
Direct,
Scielo,
Google
Scholar
databases.
quality
based
GRADE
instrument
AMSTAR-2,
risk
bias
analyzed
according
Cochrane
instrument.
Results
Conclusion:
A
total
88
articles
found.
36
evaluated
full
18
included
developed
present
study.
Considering
tool
bias,
overall
assessment
resulted
26
with
high
12
did
not
meet
AMSTAR-2.
CBD
has
been
reported
exert
range
physiological,
biochemical,
psychological
effects
potential
benefit
human
health.
For
example,
there
is
preliminary
supporting
evidence
CBD's
neuroprotective,
anxiolytic
actions
possibility
it
protect
against
gastrointestinal
damage
associated
inflammation
promote
healing
traumatic
skeletal
injuries.
combination
Δ9-THC
can
alter
activity
increasing
biosynthesis
mediators,
leading
reduction
profile.
Despite
these
findings,
still
lack
randomized
and/or
prospective
controlled
robust
sample
size
better
understand
safety
effectiveness
use
by
medium
high-performance
athletes,
as
well
dosages
each
type
sports
performance.
Language: Английский
Os efeitos do canabidiol na recuperação da dor muscular e na performance após o exercício físico: uma revisão sistemática
Matheus de Medeiros Fernandes,
No information about this author
Michela Lenzi,
No information about this author
Elvis Benjamin Bitencourt Garcao
No information about this author
et al.
Cuadernos de Educación y Desarrollo,
Journal Year:
2024,
Volume and Issue:
16(12 Edição Especial), P. e6482 - e6482
Published: Dec. 20, 2024
Introdução:
Canabidiol
(CBD),
um
composto
da
planta
Cannabis
sativa,
possui
potencial
terapêutico,
incluindo
efeitos
anticonvulsivantes
e
anti-inflamatórios.
Recentemente
autorizado
para
atletas
pela
Agência
Mundial
Antidoping,
esta
revisão
sistemática
investiga
os
do
CBD
na
recuperação
muscular
no
desempenho
após
exercícios
físicos.
Métodos:
Seguindo
diretrizes
PRISMA
o
Manual
Cochrane,
incluímos
ensaios
clínicos
randomizados,
participantes
em
físicos,
com
comparação
entre
tratamentos
sem
desfechos
relacionados
à
ou
desempenho.
Os
critérios
de
exclusão
abrangeram
estudos
envolvendo
relatos
casos,
revisões
medidas
desfecho.
As
buscas
foram
realizadas
nas
bases
dados
PubMed,
Embase
Cochrane
Central
Register
of
Controlled
Trials.
Resultados
discussão:
Onze
incluídos.
resultados
demonstraram
variáveis
físico.
Alguns
sugeriram
que
pode
reduzir
danos
musculares
dor
pós-exercício,
enquanto
outros
não
encontraram
benefícios
significativos.
Fatores
influenciam
a
eficácia
incluem
dosagem,
momento
administração
características
dos
participantes.
Considerações
finais:
evidências
indicam
inconsistentes.
Para
estabelecer
claras
sobre
uso
contextos
esportivos,
são
necessárias
pesquisas
adicionais
metodologias
rigorosas
amostras
maiores
médio
longo
prazo.